BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 19173920)

  • 1. [Evaluation of recombinant human thrombopoietin in the treatment of chemotherapy-induced thrombocytopenia in lung cancer patients].
    Xu YH; Chen ZW; Ye XY; Lu S
    Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):716-9. PubMed ID: 19173920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The clinical study of recombinant human thrombopoietin in the treatment of chemotherapy-induced severe thrombocytopenia].
    Bai CM; Zou XY; Zhao YQ; Han SM; Shan YD;
    Zhonghua Yi Xue Za Zhi; 2004 Mar; 84(5):397-400. PubMed ID: 15061993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A multi-center clinical trial of recombinant human thrombopoietin in the treatment of chemotherapy-induced thrombocytopenia in patients with solid tumor].
    Bai CM; Xu GX; Zhao YQ; Han SM; Shan YD
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Aug; 26(4):437-41. PubMed ID: 15379272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Value of recombinant human thrombopoietin in the treatment of chemotherapy-induced thrombocytopenia in patients with solid tumor].
    Dai XF; Yu J; Liu L; Wu G
    Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):623-5. PubMed ID: 19102944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Phase II clinical trial on China manufactured recombinant human interleukin-11 derivative in the prevention and treatment of chemotherapy-induced thrombocytopenia].
    Wang XY; Feng FY; Song ST; Wang HQ; Zhang MH; Liu J; Liu XY; Xu LG; Zhang Y
    Zhonghua Zhong Liu Za Zhi; 2005 Jun; 27(6):373-6. PubMed ID: 16117903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effectiveness and safety of recombinant human interleukin-11 in the treatment of chemotherapy-induced thrombocytopenia].
    Lei W; Liang J; Chen WG; Ma XZ; Xu M; Du LL
    Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):542-4. PubMed ID: 17147124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical tolerance test of recombinant human thrombopoietin].
    Zhao Y; Jiang J; Jiao L
    Zhonghua Yi Xue Za Zhi; 2001 Dec; 81(24):1508-11. PubMed ID: 16200777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Short-term intermittent prophylactic administration of recombinant human thrombopoietin attenuates chemotherapy-induced thrombocytopenia in lung cancer patients].
    Xu YH; Cheng BJ; Lu S; Jian H; Zhou Z; Chen ZW; Ye XY
    Zhonghua Zhong Liu Za Zhi; 2011 May; 33(5):395-9. PubMed ID: 21875475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical study of rhIL-11 for prevention and treatment of chemotherapy-induced thrombocytopenia].
    Sun XF; Guan ZZ; Huang H; Zhou QH; Yi C; Zhang LJ; Zhu J; Li R; Zhou J; Zhang M; Guo Y
    Ai Zheng; 2002 Aug; 21(8):892-5. PubMed ID: 12478901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effectiveness and safety of rhIL-11 in the treatment of chemotherapy-induced thrombocytopenia].
    Li L; Xu CG; Wang XW; Guo QS; Sun YH; Sun LM
    Zhonghua Zhong Liu Za Zhi; 2005 Jun; 27(6):377-9. PubMed ID: 16117904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Importance of predosing of recombinant human thrombopoietin to reduce chemotherapy-induced early thrombocytopenia.
    Vadhan-Raj S; Patel S; Bueso-Ramos C; Folloder J; Papadopolous N; Burgess A; Broemeling LD; Broxmeyer HE; Benjamin RS
    J Clin Oncol; 2003 Aug; 21(16):3158-67. PubMed ID: 12915607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prophylactic recombinant human thrombopoietin treatment alleviates chemotherapy- induced thrombocytopenia in tumor patients].
    Li Q; Ye M; Xiao W; Zhu J; Zhang S
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Jun; 32(7):1064-6. PubMed ID: 22820601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of polyethylene glycol-conjugated recombinant human megakaryocyte growth and development factor on platelet counts after chemotherapy for lung cancer.
    Fanucchi M; Glaspy J; Crawford J; Garst J; Figlin R; Sheridan W; Menchaca D; Tomita D; Ozer H; Harker L
    N Engl J Med; 1997 Feb; 336(6):404-9. PubMed ID: 9010146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant human thrombopoietin (rhTPO) after autologous bone marrow transplantation: a phase I pharmacokinetic and pharmacodynamic study.
    Wolff SN; Herzig R; Lynch J; Ericson SG; Greer JP; Stein R; Goodman S; Benyunes MC; Ashby M; Jones DV; Fay J
    Bone Marrow Transplant; 2001 Feb; 27(3):261-8. PubMed ID: 11277173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Technology evaluation: thrombopoietin, Genentech/Pharmacia & Upjohn.
    Goldberg J
    Curr Opin Mol Ther; 2000 Apr; 2(2):211-5. PubMed ID: 11249644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant human thrombopoietin attenuates carboplatin-induced severe thrombocytopenia and the need for platelet transfusions in patients with gynecologic cancer.
    Vadhan-Raj S; Verschraegen CF; Bueso-Ramos C; Broxmeyer HE; Kudelkà AP; Freedman RS; Edwards CL; Gershenson D; Jones D; Ashby M; Kavanagh JJ
    Ann Intern Med; 2000 Mar; 132(5):364-8. PubMed ID: 10691586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase I clinical, pharmacologic, and biologic study of thrombopoietin and granulocyte colony-stimulating factor in children receiving ifosfamide, carboplatin, and etoposide chemotherapy for recurrent or refractory solid tumors: a Children's Oncology Group experience.
    Angiolillo AL; Davenport V; Bonilla MA; van de Ven C; Ayello J; Militano O; Miller LL; Krailo M; Reaman G; Cairo MS;
    Clin Cancer Res; 2005 Apr; 11(7):2644-50. PubMed ID: 15814645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant human thrombopoietin improves platelet counts and reduces platelet transfusion possibility among patients with severe sepsis and thrombocytopenia: a prospective study.
    Wu Q; Ren J; Wu X; Wang G; Gu G; Liu S; Wu Y; Hu D; Zhao Y; Li J
    J Crit Care; 2014 Jun; 29(3):362-6. PubMed ID: 24405656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of transfusions of autologous cryopreserved platelets derived from recombinant human thrombopoietin to support chemotherapy-associated severe thrombocytopenia: a randomised cross-over study.
    Vadhan-Raj S; Kavanagh JJ; Freedman RS; Folloder J; Currie LM; Bueso-Ramos C; Verschraegen CF; Narvios AB; Connor J; Hoots WK; Broemeling LD; Lichtiger B
    Lancet; 2002 Jun; 359(9324):2145-52. PubMed ID: 12090979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant human thrombopoietin alleviates infection-associated thrombocytopenia: a retrospective study in senile patients.
    Lin J; Zhu H; Li S; Fan H; Lu X
    Clin Appl Thromb Hemost; 2015 Jan; 21(1):19-24. PubMed ID: 23637005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.